The Therapeutic Goods Administration (TGA) Australia has published some information regarding the manufacture of medical devices pertaining to quality management in March 2022.
Medical devices and in vitro diagnostic products (IVDs)
Regulatory News
NPRA Malaysia Publishes Updates on Guidance and Requirements on Conditional Registration of Pharmaceutical Products During Disaster
National Pharmaceutical Regulatory Agency (NPRA) Malaysia has issued the third revised version of the guidance and requirements on conditional registration of pharmaceutical products during disaster in March 2022.
The objectives of
read more...Hong Kong Drug Office Publishes Guideline on Pharmaceutical Products Recall
Hong Kong Drug Office has published some guidelines on the recall of pharmaceutical products in March 2022.
Pharmaceutical products are subjected to a recall when there is suspicion on the potential
Singapore HSA Announces Requirement for Notification of Lot Release Information of Imported Vaccines
The Health Sciences Authority (HSA) Singapore has published an update regarding the notification of lot release information of imported registered vaccines before they are supplied to Singapore, and this information
read more...Australia TGA Publishes Latest Guidance on Reclassification of Active Implantable Medical Devices
The Therapeutic Goods Administration (TGA) Australia has published the latest document on the reclassification of active implantable medical devices (AIMD) with information on transitional arrangements and obligations, in March 2022.
Active
NPRA Malaysia Publishes Frequently Asked Questions on Medicinal Gases
National Pharmaceutical Regulatory Agency (NPRA) Malaysia has issued a set of frequently asked questions (FAQs) on medicinal gases in February 2022.
The document provides detailed information on the questions and answers
read more...Singapore HSA Publishes Guidelines on Voluntary Electronic Labelling for Complementary Health Products
The Health Sciences Authority (HSA) Singapore has published a guidance document on voluntary electronic labelling for complementary health products (CHP) in March 2022.
Electronic labelling, also known as e-labelling, is information
Hong Kong Drug Office Publishes Guidance Notes on Registration of Pharmaceutical Products
Hong Kong Drug Office has published some guidance notes on the requirements of pharmaceutical products in February 2022.
Registration of pharmaceutical products needs to be completed before being sold in Hong
Singapore HSA Publishes Revised Guidance on Health Supplements Guidelines
The Health Sciences Authority (HSA) Singapore has published the latest guidance document on health supplements in March 2022.
The working definition of health supplements has been updated to be in accordance